Form 8-K - Current report:
SEC Accession No. 0001193125-25-100447
Filing Date
2025-04-28
Accepted
2025-04-28 16:05:13
Documents
18
Period of Report
2025-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d811854d8k.htm   iXBRL 8-K 41408
2 EX-4.1 d811854dex41.htm EX-4.1 181238
3 EX-10.1 d811854dex101.htm EX-10.1 660156
4 EX-10.2 d811854dex102.htm EX-10.2 141995
5 EX-99.1 d811854dex991.htm EX-99.1 14384
9 GRAPHIC g811854g0427000018323.jpg GRAPHIC 3437
  Complete submission text file 0001193125-25-100447.txt   1391866

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA xgn-20250425.xsd EX-101.SCH 2875
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xgn-20250425_lab.xml EX-101.LAB 17236
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xgn-20250425_pre.xml EX-101.PRE 10830
20 EXTRACTED XBRL INSTANCE DOCUMENT d811854d8k_htm.xml XML 3481
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 25880236
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)